Bhekisisa analysis
— South Africa will receive its first batch of the once-every-six-months HIV prevention shot, lenacapavir, soon. Roll-out in government clinics is set to start within the next couple of months, the health department says — depending on when the first batch of medicine arrives, and by when samples of the shipment have been quality-tested.
— The government will have to dig deep in its pocketbook to make sure the country reaps the full benefit of this prevention medicine in the aftermath of the Trump administration’s defunding shocks of 2025.
— The first batch is part of doses paid for by the Global Fund to Fight AIDS, TB and Malaria. But in total, the Fund will only donate 3% of the stock required to end AIDS by 2043 in the country. The rest would mostly need to come from the national and provincial health departments’ own budgets.
So how best to spend the HIV prevention budget so that South Africa can drive infections down as fast as possible?
Bhekisisa takes a look at what modelling data shows.
Read the full analysis here.
Source : Bhekisisa
Related HIV and Co-Infections News
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
EurekAlert!: Between 2.4 and 4.1 million people estimated to be living with chronic hepatitis B infection in Europe
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.